These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 31809537)

  • 1. End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.
    Farrell AT; Panepinto J; Desai AA; Kassim AA; Lebensburger J; Walters MC; Bauer DE; Blaylark RM; DiMichele DM; Gladwin MT; Green NS; Hassell K; Kato GJ; Klings ES; Kohn DB; Krishnamurti L; Little J; Makani J; Malik P; McGann PT; Minniti C; Morris CR; Odame I; Oneal PA; Setse R; Sharma P; Shenoy S
    Blood Adv; 2019 Dec; 3(23):4002-4020. PubMed ID: 31809537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.
    Farrell AT; Panepinto J; Carroll CP; Darbari DS; Desai AA; King AA; Adams RJ; Barber TD; Brandow AM; DeBaun MR; Donahue MJ; Gupta K; Hankins JS; Kameka M; Kirkham FJ; Luksenburg H; Miller S; Oneal PA; Rees DC; Setse R; Sheehan VA; Strouse J; Stucky CL; Werner EM; Wood JC; Zempsky WT
    Blood Adv; 2019 Dec; 3(23):3982-4001. PubMed ID: 31809538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.
    Liem RI; Lanzkron S; D Coates T; DeCastro L; Desai AA; Ataga KI; Cohen RT; Haynes J; Osunkwo I; Lebensburger JD; Lash JP; Wun T; Verhovsek M; Ontala E; Blaylark R; Alahdab F; Katabi A; Mustafa RA
    Blood Adv; 2019 Dec; 3(23):3867-3897. PubMed ID: 31794601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial considerations in sickle cell disease: patient-reported outcomes, data elements, and the stakeholder engagement framework.
    Badawy SM
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):196-205. PubMed ID: 34889394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.
    Gladwin MT; Kato GJ
    Hematology Am Soc Hematol Educ Program; 2005; ():51-7. PubMed ID: 16304359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney ultrasound findings according to kidney function in sickle cell anemia.
    Patel R; Kang S; Valeshabad AK; Shah BN; Han J; Gowhari M; Molokie RE; Xie K; Lash JP; Gordeuk VR; Saraf SL
    Am J Hematol; 2019 Nov; 94(11):E288-E291. PubMed ID: 31379007
    [No Abstract]   [Full Text] [Related]  

  • 7. Thoracic manifestations of sickle cell disease.
    Leong CS; Stark P
    J Thorac Imaging; 1998 Apr; 13(2):128-34. PubMed ID: 9556290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiopulmonary complications in sickle cell anemia].
    Rojas-Jiménez S; Lopera-Valle J; Yabur-Espítia M
    Arch Cardiol Mex; 2013; 83(4):289-94. PubMed ID: 24215682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.
    Asnani MR; Quimby KR; Bennett NR; Francis DK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011175. PubMed ID: 27711980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional capacity in children and young adults with sickle cell disease undergoing evaluation for cardiopulmonary disease.
    Liem RI; Nevin MA; Prestridge A; Young LT; Thompson AA
    Am J Hematol; 2009 Oct; 84(10):645-9. PubMed ID: 19705433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell anemia and related hemoglobinopathies.
    Vichinsky EP; Lubin BH
    Pediatr Clin North Am; 1980 May; 27(2):429-47. PubMed ID: 6155657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Sickle Cell Disease in Children.
    Noronha SA; Sadreameli SC; Strouse JJ
    South Med J; 2016 Sep; 109(9):495-502. PubMed ID: 27598348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The heart in sickle cell anemia.
    Falk RH; Hood WB
    Arch Intern Med; 1982 Sep; 142(9):1680-4. PubMed ID: 7114987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary orosomucoid is associated with progressive chronic kidney disease stage in patients with sickle cell anemia.
    Jerebtsova M; Saraf SL; Soni S; Afangbedji N; Lin X; Raslan R; Gordeuk VR; Nekhai S
    Am J Hematol; 2018 Aug; 93(4):E107-E109. PubMed ID: 29327376
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sickle cell anemia and the heart].
    Bertrand E
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1881-4. PubMed ID: 2514641
    [No Abstract]   [Full Text] [Related]  

  • 16. The lung in sickle cell disease.
    Knight J; Murphy TM; Browning I
    Pediatr Pulmonol; 1999 Sep; 28(3):205-16. PubMed ID: 10495338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heart in sickle-cell anemia (author's transl)].
    Mazaud R
    Med Trop (Mars); 1978; 38(2):189-96. PubMed ID: 723564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease.
    Xu JZ; Garrett ME; Soldano KL; Chen ST; Clish CB; Ashley-Koch AE; Telen MJ
    Am J Hematol; 2018 Dec; 93(12):1451-1460. PubMed ID: 30144150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait.
    Naik RP; Derebail VK
    Expert Rev Hematol; 2017 Dec; 10(12):1087-1094. PubMed ID: 29048948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle Cell Disease: A Brief Update.
    Azar S; Wong TE
    Med Clin North Am; 2017 Mar; 101(2):375-393. PubMed ID: 28189177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.